GM
TEVA icon

GeoWealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

GeoWealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$706K Buy
20,848
+17,291
+486% +$576K 0.02% 413
2026
Q1 		$107K Buy
+3,557
New +$114K ﹤0.01% 784
2025
Q1 		– Sell
-2,398
Closed -$52.9K – 1728
2024
Q4 		$52.9K Sell
2,398
-150
-6% -$2.73K ﹤0.01% 1145
2024
Q3 		$45.9K Buy
+2,548
New +$44.6K ﹤0.01% 1097

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

GeoWealth Management's TEVA Position: Q2 2026 in Review

GeoWealth Management increased its Teva Pharmaceuticals (TEVA) stake by 486% in Q2 2026, buying an estimated $576K and bringing the position to 20,848 shares worth $706K. The position accounts for 0.02% of the portfolio, ranked #413.

GeoWealth Management first reported a position in TEVA in Q3 2024 and has held it in 4 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • GeoWealth Management held 20,848 shares of Teva Pharmaceuticals worth $706K as of Q2 2026.
  • GeoWealth Management bought 17,291 Teva Pharmaceuticals shares in Q2 2026, an estimated $576K.
  • Teva Pharmaceuticals made up 0.02% of GeoWealth Management's portfolio in Q2 2026, its #413 holding.
  • GeoWealth Management first reported a position in Teva Pharmaceuticals in Q3 2024 and has held it in 4 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on GeoWealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.